Greg J Towers Selected Research

Bone Marrow Stromal Antigen 2

12/2013	Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M.
12/2011	Analysis of the human immunodeficiency virus type 1 M group Vpu domains involved in antagonizing tetherin.
6/2011	Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection.
4/2010	Ultra structural characterisation of tetherin - a protein capable of preventing viral release from the plasma membrane.
12/2009	Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.
5/2009	Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Greg J Towers Research Topics

Disease

31	Infections 01/2021 - 03/2003
8	Virus Diseases (Viral Diseases) 04/2013 - 06/2007
4	COVID-19 01/2022 - 01/2021
4	HIV Infections (HIV Infection) 01/2019 - 11/2007
2	Bites and Stings (Sting) 09/2021 - 01/2018
1	Inflammation (Inflammations) 01/2021
1	Smallpox (Variola) 01/2018
1	Cowpox 01/2018
1	Reperfusion Injury 02/2016
1	Multiple Sclerosis 02/2016
1	Arthritis (Polyarthritis) 11/2014
1	Viremia 10/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2013
1	Autoimmune Diseases (Autoimmune Disease) 09/2013
1	Starvation 09/2013
1	Retroviridae Infections (Infection, Retrovirus) 03/2011
1	Neoplasms (Cancer) 03/2011
1	Communicable Diseases (Infectious Diseases) 06/2007
1	Acute Promyelocytic Leukemia 03/2003

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 09/2021 - 07/2003
9	Antiviral Agents (Antivirals)IBA 01/2019 - 06/2007
6	Viral DNAIBA 10/2020 - 10/2005
6	Bone Marrow Stromal Antigen 2IBA 12/2013 - 05/2009
5	InterferonsIBA 09/2021 - 11/2009
4	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 09/2005
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016 - 08/2006
3	Interferon Type IIBA 01/2022 - 09/2013
3	AntibodiesIBA 01/2022 - 11/2010
3	Pharmaceutical PreparationsIBA 02/2016 - 03/2003
3	Tripartite Motif ProteinsIBA 04/2013 - 08/2006
2	plitidepsin (aplidine)IBA 01/2022 - 05/2021
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 09/2021 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 09/2021 - 11/2009
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	NucleotidesIBA 01/2016 - 09/2013
2	Cyclophilin AIBA 02/2009 - 06/2007
1	Neutralizing AntibodiesIBA 01/2022
1	Poly I-CIBA 09/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 09/2021
1	ProteomeIBA 09/2021
1	CytokinesIBA 01/2021
1	A-Form DNA (A-DNA)IBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	Deoxyribonucleases (DNase)FDA Link 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 01/2018
1	Topoisomerase InhibitorsIBA 01/2018
1	Mitochondrial Permeability Transition PoreIBA 02/2016
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 11/2014
1	HLA-B Antigens (HLA-B)IBA 10/2013
1	HLA-B57 antigenIBA 10/2013
1	EpitopesIBA 10/2013
1	triphosphoric acid (triphosphate)IBA 09/2013
1	NucleoproteinsIBA 04/2013
1	Messenger RNA (mRNA)IBA 04/2013
1	Viral AntigensIBA 03/2011
1	AntigensIBA 03/2011
1	ran-binding protein 2IBA 03/2011
1	Small Interfering RNA (siRNA)IBA 03/2011
1	Karyopherins (Importin)IBA 03/2011
1	Pattern Recognition ReceptorsIBA 11/2009
1	NF-kappa B (NF-kB)IBA 11/2009
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 11/2009
1	Arsenic Trioxide (Trisenox)FDA Link 11/2007
1	ArsenicIBA 11/2007
1	ImmunophilinsIBA 08/2006
1	Promyelocytic Leukemia ProteinIBA 07/2004
1	Aligeron (AS 2)IBA 03/2003

Therapy/Procedure

2	Therapeutics 01/2021 - 10/2016
1	Intravenous Infusions 05/2021